Compare your options

Comparing semaglutide and tirzepatide beyond a weight-loss percentage

Consider product identity, your medical history, treatment experience, support, and sustainable cost when comparing these options.

By Sema vs Tirz · Published · Updated · 3 min read

This article promotes CoreAge Rx and includes commercial links. Service claims are attributed to CoreAge Rx; medical and regulatory information is linked to its sources.

General education; individual care decisions require a licensed clinician. This article does not report a clinical review or study of CoreAge Rx patients.

The quick answer

A weight-loss percentage is one piece of a medication comparison. A clinician also needs to consider the exact product, your health history, other medicines, possible adverse effects, and whether you can follow the plan. Research averages do not choose the right treatment for an individual or establish outcomes for a compounded product.

Understand the basic difference without overreading it

Semaglutide acts on the GLP-1 pathway; tirzepatide acts on GIP and GLP-1 pathways. NIDDK describes these mechanisms in its overview of weight-management medicines. Read the medication summary. The mechanism helps explain why they are different medicines, but it cannot predict your individual response.

When discussing a study, name the actual product and the population studied. Compare like with like before drawing conclusions from different trial durations, regimens, or patient groups. A clinician can help interpret which evidence is relevant to your circumstances.

Bring your own treatment experience into the comparison

Tell the clinician what you have previously tried, what benefit or difficulty you experienced, and whether there were treatment gaps. Include current medicines and health concerns. An experience with one option can be relevant without proving that a different medicine will solve the problem.

If the reason for switching is communication or delivery, separate that service issue from a medication question. Changing the drug and changing the provider are different decisions, even when they happen at the same time.

Identify the actual products available

A provider may offer approved branded products, compounded products, or different arrangements for each. Ask what is actually proposed for you. FDA explains that compounded drugs are not FDA-approved and are distinct from approved generics. Read its explanation.

Do not compare a compounded offer’s price with a branded trial outcome as though they establish one combined proposition. Ask whether an approved medicine can meet your medical needs and why a particular product is recommended.

Compare the care you would receive

Treatment needs a practical plan as well as a product choice. Ask these questions for each option rather than assuming the program details are identical.

  • How will benefits and side effects be assessed?
  • What follow-up and pharmacy support are available?
  • What will the actual prescribed plan cost over the same period?
  • What happens if I need to pause, change treatment, or transfer care?

Apply the comparison to CoreAge Rx

CoreAge Rx lists separate compounded semaglutide and compounded tirzepatide offers. Use our CoreAge Rx review to research the service, then confirm the product, terms, and clinical recommendation for your situation.

Our comparison guides provide background for a more specific conversation. The goal is to understand why a choice fits your care, not to select the largest number from a headline.

Common questions

Does a dual mechanism automatically mean a better choice for me?

No. Mechanism is one factor; the clinical assessment and exact product matter.

Can I convert a semaglutide dose to a tirzepatide dose myself?

No. A change between medicines requires prescriber guidance. Do not use an online conversion as a treatment plan.

Sources and fact-checking

Sources checked 2026-09-09. CoreAge Rx pages support descriptions of its service; medical and regulatory sources support the educational context. Offers and availability can change.

  1. NIDDK: prescription medications for overweight and obesity
  2. FDA: compounding questions and answers
  3. CoreAge Rx: semaglutide product information
  4. CoreAge Rx: tirzepatide product information
  5. FDA: concerns with unapproved GLP-1 drugs